Advertisement
U.S. Markets closed

Arecor Therapeutics plc (AREC.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
77.00+2.50 (+3.36%)
At close: 09:09AM GMT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,573
4,573
2,403
1,158
1,698
Gross Profit
-
-
-
1,158
1,698
Operating Expense
13,748
13,748
12,915
7,597
5,126
Operating Income
-9,175
-9,175
-10,512
-6,439
-3,428
Net Non Operating Interest Income Expense
269
269
88
-506
-84
Pretax Income
-8,901
-8,901
-10,424
-6,945
-3,512
Tax Provision
-347
-347
-1,164
-776
-760
Net Income Common Stockholders
-8,554
-8,554
-9,260
-6,169
-2,752
Diluted NI Available to Com Stockholders
-8,554
-8,554
-9,260
-6,169
-2,752
Basic EPS
-0.31
-0.00
-0.00
-0.27
-0.10
Diluted EPS
-0.31
-0.00
-0.00
-0.27
-0.10
Basic Average Shares
30,328
30,623
28,936
23,033
27,684
Diluted Average Shares
30,328
30,623
28,936
23,033
27,684
Total Operating Income as Reported
-9,175
-9,175
-10,512
-6,439
-3,428
Total Expenses
13,748
13,748
12,915
7,597
5,126
Net Income from Continuing & Discontinued Operation
-8,554
-8,554
-9,260
-6,169
-2,752
Normalized Income
-8,554
-8,554
-9,260
-6,169
-2,752
Interest Income
284
284
109
1
3
Interest Expense
15
15
21
22
82
Net Interest Income
269
269
88
-506
-84
EBIT
-8,886
-8,886
-10,403
-6,923
-3,430
EBITDA
-8,390
-8,390
-10,062
-6,752
-3,262
Reconciled Depreciation
496
496
341
171
168
Net Income from Continuing Operation Net Minority Interest
-8,554
-8,554
-9,260
-6,169
-2,752
Total Unusual Items Excluding Goodwill
-
-
-
-462
0
Total Unusual Items
-
-
-
-462
0
Normalized EBITDA
-8,390
-8,390
-10,062
-6,752
-3,262
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0